Nagao, S., Kogiku, A., Suzuki, K., Shibutani, T., Yamamoto, K., Jimi, T., . . . Yamaguchi, S. (2020). A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Ovarian Res.
Čikaški stil citiranjaNagao, Shoji, et al. "A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer." J Ovarian Res 2020.
MLA način citiranjaNagao, Shoji, et al. "A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer." J Ovarian Res 2020.